Judge Questions Difference Between Hegseth's Testosterone Policy and Transgender Care Policy for Troops
Judge Ana Reyes ordered the Pentagon to explain why its testosterone screening plan differs from hormone treatment for transgender troops.
- On Wednesday, U.S. District Judge Ana Reyes questioned the Pentagon's new testosterone replacement therapy initiative, ordering both parties in a lawsuit challenging the military's transgender troop ban to compare how TRT is administered to transgender troops versus other service members.
- Defense Secretary Pete Hegseth announced last week that the Pentagon will conduct annual testosterone screenings for service members aged 30 and older, offering voluntary treatment to those with low levels, calling it necessary for troops to operate at their "absolute best."
- Transgender active-duty service members sued the administration in January 2025, alleging the military ban violates due process. Reyes granted the case class-action status, meaning the court's ruling could affect all service members challenging the policy.
- Reyes ordered both parties to address the medical and logistical similarities between the new TRT policy and the military ban in upcoming briefs. She requested information on the Pentagon's basis for treating transgender troops differently from other service members.
- Although a federal appeals panel partially upheld Reyes's rulings last year, the transgender military ban remains in effect. The Supreme Court has allowed the Pentagon to enforce the policy while litigation continues in the lower courts.
23 Articles
23 Articles
Hegseth's Testosterone Plan Catches Federal Judge's Eye
Defense Secretary Pete Hegseth's initiative to test and treat troops for low testosterone has prompted a federal judge to question the differences between that kind of testosterone replacement therapy and hormone treatment for transgender men in the military. US District Judge Ana Reyes in Washington raised the question Wednesday in...
Judge asks whether 'High-T' plan undercuts transgender troops ban
A federal judge is questioning whether the Pentagon’s new testosterone initiative undermines its legal defense of restrictions on transgender troops, ordering the government to explain why hormone treatment is acceptable for some service members yet disqualifying when provided for gender dysphoria. U.S. District Judge Ana C. Reyes took notice Wednesday of War Secretary Pete Hegseth’s recent announcement that troops 30 and older would be screened…
Judge asks Pentagon how troop TRT differs from care denied to trans men
A US judge has asked the Pentagon to explain how testosterone therapy for troops differs from hormone treatment for transgender men. The order sharpens scrutiny of the military's unequal medical standards as Trump's ban remains in force.
Judge orders DoD to explain the conflict between Hegseth's TRT plan and Trump's trans ban
“Secretary of War” and ultimate “alpha male” Pete Hegseth’s manly new policy promoting testosterone treatments to U.S. military servicemen over the age of 30 has been called into question by a federal judge who wants to know why certain people in the military are being offered gender-affirming care at the same time the Trump-Hegseth juggerNOT is forcefully discharging transgender members of the military because, in part, the government can’t aff…
‘The court must assess’: Judge who ruled against transgender ban wants answers now that Pentagon is providing hormone therapy to certain troops
Left: Defense Secretary Pete Hegseth speaks in the James Brady Press Briefing Room at the White House, Thursday, Jan. 30, 2025, in Washington (AP Photo/Alex Brandon). Right: U.S. District Judge Ana C. Reyes during her confirmation hearings in June 2022 (U.S. Senate/YouTube). A federal judge is demanding answers from Secretary of Defense Pete Hegseth in...
Coverage Details
Bias Distribution
- 38% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
